Page 80

Marzo_2017

artículo de investigación Clínica y mortalidad en síndrome hemofagocítico - F. Warley et al hemophagocyticlymphohistiocytosis. Cancer Control 2014; 21: 301-12. 3. Janka GE. Familial and acquired hemophagocyticlymphohistiocytosis. 350 Eur J Pediatr 2007; 166: 95-109. 4. Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, et al. Recent advances in the diagnosis and treatment of hemophagocyticlymphohistiocytosis. Arthritis Res Ther 2012; 14: 213. 5. Janka GE, Lehmberg K. Hemophagocytic syndromes-an update. Blood Rev 2014; 28: 135-42. 6. Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011; 118: 4577-84. 7. Machaczka M, Sydor W, Rucinska M, Szostek M, Musia J. Autoimmune-Associated Hemophagocytic Syndrome/ Macrophage Activation Syndrome. Autoimmune Disorders - Current Concepts and Advances from Bedside to Mechanistic Insights. 2011. 8. Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation 2004; 77: 238-43. 9. Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 2015; 90: 220-4. 10. Henter J-I, Jan-Inge H, AnnaCarin H, Maurizio A, Maarten Egeler R, Filipovich AH, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31. 11. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood 2011; 118: 4041-52. 12. EgüesDubuc C, Dubuc CE, Cáceres VA, Ecenarro MU, Aguirre NE, Rubio IH, et al. Secondary Macrophage Activation Syndrome Due to Autoimmune, Hematologic, Infectious and Oncologic Diseases. Thirteen Case Series and Review of the Literature. Reumatología Clínica (English Edition) 2015; 11: 139-43. 13. Oto M, Yoshitsugu K, Uneda S, Nagamine M, Yoshida M. Prognostic Factors and Outcomes of Adult-Onset Hemophagocytic lymphohistiocytosis: A Retrospective Analysis of 34 Cases. Hematol Rep 2015; 7: 5841. 14. Zhang Z, Wang J, Ji B, Greenwood T, Zhang Y, Wang Y, et al. Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children. Clinics 2016; 71: 205-9. 15. Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood 2015; 125: 2908-14. 16. Reddy S, Rangappa P, Kasaragod A, Kumar AS, Rao K. Haemophagocytic lymphohistiocytosis (HLH): case series in tertiary referral hospital over three years. J Assoc Physicians India 2013; 61: 850-2. 17. Young P, Peroni J, Finn BC, Venditti JE, Preiti V, Bullorsky E, et al. Síndromehematofagocítico: Reporte de cuatro casos y revisión de la literatura. Rev Med Chile 2011; 139: 224-9. 18. Kleinert MM, Garate G, Osatnik J, Cicco J, Hunter B, Soria EJ. Reactive hemophagocytic syndrome in critical care patients. Report of 4 cases. Medicina 2007; 67: 49- 52. 19. Mahuad CV, Garate GM, Vicente Reparaz M de L, Casali C, Del Olmo M, Bolgiani A. Secondary hemophagocytic syndrome due to recurrent infections in a severely burned patient. Medicina 2013; 73: 255-8. Rev Med Chile 2017; 145: 344-350


Marzo_2017
To see the actual publication please follow the link above